SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19.
COVID-19
Guidelines
Laparoscopy
Safety
Surgical plume
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
23
01
2022
accepted:
10
02
2022
pubmed:
4
3
2022
medline:
15
4
2022
entrez:
3
3
2022
Statut:
ppublish
Résumé
SARS-CoV-2 has changed global healthcare since the pandemic began in 2020. The safety of minimally invasive surgery (MIS) utilizing insufflation from the standpoint of safety to the operating room personnel is currently being explored. The aims of this guideline are to examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved. Systematic literature reviews were conducted for 2 key questions (KQ) regarding the safety of MIS in the setting of COVID-19 pandemic. Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis criteria. Evidence-based recommendations were formulated using a narrative synthesis of the literature by subject experts. Recommendations for future research were also proposed. In KQ1, a total of 1361 articles were reviewed, with 2 articles meeting inclusion. In KQ2, a total of 977 articles were reviewed, with 4 articles met inclusions criteria, of which 2 studies reported on the SARS-CoV2 virus specifically. Despite many publications in the field, very little well-controlled and unbiased data exist to inform the recommendations. Of that which is available, it shows that both laparoscopic and open operations in Covid-positive patients had similar rates of OR staff positivity rates; however, patients who underwent laparoscopic procedures had a lower perioperative mortality than open procedures. Also, SARS-CoV-2 particles have been detected in the surgical plume at laparoscopy. With demonstrated equivalence of operating room staff exposure, and noninferiority of laparoscopic access with respect to mortality, either laparoscopic or open approaches to abdominal operations may be used in patients with SARS-CoV-2. Measures should be employed for all laparoscopic or open cases to prevent exposure of operating room staff to the surgical plume, as virus can be present in this plume.
Sections du résumé
BACKGROUND
SARS-CoV-2 has changed global healthcare since the pandemic began in 2020. The safety of minimally invasive surgery (MIS) utilizing insufflation from the standpoint of safety to the operating room personnel is currently being explored. The aims of this guideline are to examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved.
METHODS
Systematic literature reviews were conducted for 2 key questions (KQ) regarding the safety of MIS in the setting of COVID-19 pandemic. Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis criteria. Evidence-based recommendations were formulated using a narrative synthesis of the literature by subject experts. Recommendations for future research were also proposed.
RESULTS
In KQ1, a total of 1361 articles were reviewed, with 2 articles meeting inclusion. In KQ2, a total of 977 articles were reviewed, with 4 articles met inclusions criteria, of which 2 studies reported on the SARS-CoV2 virus specifically. Despite many publications in the field, very little well-controlled and unbiased data exist to inform the recommendations. Of that which is available, it shows that both laparoscopic and open operations in Covid-positive patients had similar rates of OR staff positivity rates; however, patients who underwent laparoscopic procedures had a lower perioperative mortality than open procedures. Also, SARS-CoV-2 particles have been detected in the surgical plume at laparoscopy.
CONCLUSION
With demonstrated equivalence of operating room staff exposure, and noninferiority of laparoscopic access with respect to mortality, either laparoscopic or open approaches to abdominal operations may be used in patients with SARS-CoV-2. Measures should be employed for all laparoscopic or open cases to prevent exposure of operating room staff to the surgical plume, as virus can be present in this plume.
Identifiants
pubmed: 35237900
doi: 10.1007/s00464-022-09133-w
pii: 10.1007/s00464-022-09133-w
pmc: PMC8890462
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2723-2733Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Ann Intern Med. 2017 Jan 17;166(2):128-132
pubmed: 27893062
Turk J Surg. 2020 Mar 31;36(1):i-v
pubmed: 32637887
CJC Open. 2021 Oct;3(10):1217-1220
pubmed: 34109309
Int Arch Occup Environ Health. 2021 Jan;94(1):107-115
pubmed: 32870342
Updates Surg. 2021 Apr;73(2):763-768
pubmed: 33625679
Ann R Coll Surg Engl. 2021 May;103(5):354-359
pubmed: 33682443
Surg Endosc. 2021 Jun;35(6):2417-2427
pubmed: 33871718
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
BMJ. 2020 Mar 18;368:m1106
pubmed: 32188602
World J Otorhinolaryngol Head Neck Surg. 2020 Nov;6:S6-S10
pubmed: 32837763
Occup Environ Med. 2016 Dec;73(12):857-863
pubmed: 27484956
JAMA Surg. 2021 Sep 1;156(9):883-885
pubmed: 34019099
Surg Laparosc Endosc Percutan Tech. 2020 Dec;30(6):e43-e45
pubmed: 32694404
AORN J. 2017 May;105(5):498-500
pubmed: 28454615
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
ORNAC J. 2012 Mar;30(1):14-6, 18-9, 35-7
pubmed: 22783605
J Minim Invasive Gynecol. 2021 Aug;28(8):1519-1525
pubmed: 33373728
CMAJ Open. 2022 May 24;10(2):E450-E459
pubmed: 35609928
Br J Surg. 2020 Sep;107(10):e395-e397
pubmed: 32725815